CompoSecure raises 2025 guidance after strong Q3 results

CompoSecure (NYSE:CMPO) reported robust third-quarter results, with non-GAAP net sales increasing 13% year-over-year to $120.9 million and non-GAAP pro forma adjusted EBITDA rising 30% to $47.7 million, driven by strong demand and margin expansion. The company also announced a significant $7.4 billion business combination with Husky Technologies, raised its full-year 2025 guidance, and improved its net cash position to $75.3 million. Despite positive price target revisions and Buy ratings from Needham and Benchmark, JPMorgan downgraded the stock to Underweight, citing valuation concerns following a substantial rally.

Analysis

CompoSecure (CMPO) reported robust third-quarter results, with non-GAAP net sales increasing 13% year-over-year to $120.9 million and non-GAAP pro forma adjusted EBITDA rising 30% to $47.7 million, significantly exceeding expectations. This strong performance was driven by customer demand and new program wins, leading to a notable gross margin expansion to 59.0% from 51.7% in the prior year. The company also improved its financial health, shifting from a net debt of $277.3 million to a net cash position of $75.3 million.

The company announced a significant strategic move with a business combination with Husky Technologies, valued at approximately $7.4 billion, expected to close in Q1 2026, subject to regulatory approval. Concurrently, CompoSecure raised its full-year 2025 guidance, now projecting non-GAAP net sales of $463 million and EBITDA of $165-170 million, with FY2026 sales forecast at $510 million, indicating continued growth.

Despite strong operational momentum and positive revisions from Needham and Benchmark, who raised price targets to $22 and $24 respectively with Buy ratings, analyst sentiment is mixed. JPMorgan downgraded CMPO to Underweight from Neutral, citing valuation concerns following a 25% rally in shares post-Q2 earnings and a 60% price return over the past year, with the stock trading near its 52-week high of $21.16.

Key Decisions for Investors

• Investors should assess the sustainability of CompoSecure's organic growth and margin expansion, particularly given the strong Q3 performance and raised full-year guidance.
• Monitor the progress and regulatory approval of the $7.4 billion business combination with Husky Technologies, as this transaction represents a significant future growth driver and potential re-rating event.
• Consider the divergent analyst opinions, weighing the company's operational strength and positive outlook against JPMorgan's valuation concerns, especially given the stock's recent substantial rally and current trading levels.